Oral chronic graft-versus-host disease following allogeneic conventional myeloablative versus non-myeloablative stem cell transplantation

被引：0
|
作者：
Demarosi, F [1 ]
Soligo, D [1 ]
Carrassi, A [1 ]
Deliliers, GL [1 ]
Manusè, I [1 ]
Minazzi, C [1 ]
Sardella, A [1 ]
机构：
[1] Univ Milan, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [41] Non-myeloablative stem cell transplantation - High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation
    Passweg, JR
    Meyer-Monard, S
    Gregor, M
    Favre, G
    Heim, D
    Ebnoether, M
    Tichelli, A
    Gratwohl, A
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 267 - 271
  • [42] Risk for cytomegalovirus infection following non-myeloablative allogeneic stem cell transplantation
    Nachbaur, D
    Gunsilius, E
    Haun, M
    Larcher, C
    Gastl, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S96 - S97
  • [43] MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation
    Ciprian Tomuleasa
    Shigeo Fuji
    Andrei Cucuianu
    Markus Kapp
    Valentina Pileczki
    Bobe Petrushev
    Sonia Selicean
    Alina Tanase
    Delia Dima
    Ioana Berindan-Neagoe
    Alexandru Irimie
    Hermann Einsele
    Annals of Hematology, 2015, 94 : 1081 - 1092
  • [44] Phase I Study of Urate Oxidase in the Reduction of Acute Graft-Versus-Host Disease after Myeloablative Allogeneic Stem Cell Transplantation
    Yeh, Albert C.
    Brunner, Andrew M.
    Spitzer, Thomas R.
    Chen, Yi-Bin
    Coughlin, Erin
    McAfee, Steven
    Ballen, Karen
    Attar, Eyal
    Caron, Martin
    Preffer, Frederic I.
    Yeap, Beow Y.
    Dey, Bimalangshu R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (05) : 730 - 734
  • [45] Genital graft-versus-host disease in a male following allogeneic stem cell transplantation
    Nylander, Elisabet
    Wahlin, Ylva Britt
    Lundskog, Bertil
    Wahlin, Anders
    ACTA DERMATO-VENEREOLOGICA, 2007, 87 (04) : 367 - 368
  • [46] MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation
    Tomuleasa, Ciprian
    Fuji, Shigeo
    Cucuianu, Andrei
    Kapp, Markus
    Pileczki, Valentina
    Petrushev, Bobe
    Selicean, Sonia
    Tanase, Alina
    Dima, Delia
    Berindan-Neagoe, Ioana
    Irimie, Alexandru
    Einsele, Hermann
    ANNALS OF HEMATOLOGY, 2015, 94 (07) : 1081 - 1092
  • [47] The importance of chronic graft-versus-host disease after myeloablative stem cell transplantation for imatinib resistant advanced phase CML
    Batai, A.
    Remenyi, P.
    Kapas, B.
    Sipos, A.
    Csukly, Z.
    Lueff, S.
    Reti, M.
    Goda, V.
    Masszi, T.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S411 - S411
  • [48] Toward optimization of cyclosporine concentration target to prevent acute graft-versus-host disease following myeloablative allogeneic stem cell transplant
    Kwan, Alex Chi Fung
    Blosser, Nikki
    Ghosh, Sunita
    Leyshon, Catherine
    Dersch-Mills, Deonne
    Puckrin, Robert
    Duggan, Peter
    Zepeda, Victor
    Savoie, Lynn
    Stewart, Douglas
    Storek, Jan
    Jamani, Kareem
    CLINICAL TRANSPLANTATION, 2022, 36 (08)
  • [49] Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation
    Stratton, Pamela
    Turner, Maria L.
    Childs, Richard
    Barrett, John
    Bishop, Michael
    Wayne, Alan S.
    Pavletic, Steven
    OBSTETRICS AND GYNECOLOGY, 2007, 110 (05): : 1041 - 1049
  • [50] Chronic graft-versus-host disease after allogeneic blood stem cell transplantation
    Przepiorka, D
    Anderlini, P
    Saliba, R
    Cleary, K
    Mehra, R
    Khouri, I
    Huh, YO
    Giralt, S
    Braunschweig, I
    van Besien, K
    Champlin, R
    BLOOD, 2001, 98 (06) : 1695 - 1700
12345